PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 36 filers reported holding PROTARA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $131,151 | -34.2% | 78,518 | -5.9% | 0.00% | – |
| Q2 2023 | $199,373 | -22.9% | 83,420 | 0.0% | 0.00% | – |
| Q1 2023 | $258,602 | +115865.0% | 83,420 | 0.0% | 0.00% | – |
| Q4 2022 | $223 | -99.9% | 83,420 | -0.3% | 0.00% | – |
| Q3 2022 | $247,000 | +0.8% | 83,644 | 0.0% | 0.00% | – |
| Q2 2022 | $245,000 | -41.4% | 83,644 | +2.0% | 0.00% | – |
| Q1 2022 | $418,000 | -21.6% | 81,964 | +3.7% | 0.00% | – |
| Q4 2021 | $533,000 | -2.4% | 79,017 | 0.0% | 0.00% | – |
| Q3 2021 | $546,000 | -32.4% | 79,017 | -4.8% | 0.00% | – |
| Q2 2021 | $808,000 | -53.8% | 82,985 | -25.3% | 0.00% | – |
| Q1 2021 | $1,748,000 | -31.2% | 111,062 | +5.9% | 0.00% | – |
| Q4 2020 | $2,539,000 | +644.6% | 104,880 | +417.1% | 0.00% | – |
| Q3 2020 | $341,000 | -33.3% | 20,282 | +16.3% | 0.00% | – |
| Q2 2020 | $511,000 | – | 17,444 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,558,472 | $43,059,000 | 8.42% |
| CVI Holdings, LLC | 168,836 | $2,842,000 | 1.16% |
| Soleus Capital Management, L.P. | 100,000 | $1,683,000 | 0.89% |
| Ikarian Capital, LLC | 722,443 | $12,158,000 | 0.88% |
| COWEN AND COMPANY, LLC | 124,171 | $2,090,000 | 0.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 782,670 | $13,172,000 | 0.32% |
| Cormorant Asset Management, LP | 450,000 | $7,574,000 | 0.29% |
| Rock Springs Capital Management LP | 643,622 | $10,832,000 | 0.28% |
| Perceptive Advisors | 608,544 | $10,242,000 | 0.15% |
| Maven Securities LTD | 100,000 | $1,688,000 | 0.14% |